Resources

Publish Date
Public Comments
C4IP Post-Hearing Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Public Comments
C4IP Comments RE: The 2026 Special 301 Review (USTR-2025-0243)
Public Comments
C4IP Response RE: OSTP RFI on Accelerating American Scientific Enterprise
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: the American Music Fairness Act of 2025
Letters
C4IP Letter to USTR RE: US-EU Trade Agreement
Public Comments
C4IP Comments RE: Revision to Rules of Practice Before PTAB (PTO-P-2025-0025)
Infographics & Fact Sheets
PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB
Public Comments
C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime
Public Comments
C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004)
Letters
C4IP Letter to Senate and House IP Subcommittees RE: Designating October as National IP Month
Letters
C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA Hearing
Public Comments
C4IP Comments RE: U.K. IPO Consultation on SEPs
Resources:

Resources:

C4IP Post-Hearing Comments RE: The 2026 Special 301 Review (USTR-2025-0243),

02/25/2026

Resources:

Resources:

C4IP Comments RE: The 2026 Special 301 Review (USTR-2025-0243),

01/28/2026

Resources:

Resources:

C4IP Response RE: OSTP RFI on Accelerating American Scientific Enterprise,

12/26/2025

Resources:

Resources:

C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: the American Music Fairness Act of 2025,

12/09/2025

Resources:

Resources:

C4IP Letter to USTR RE: US-EU Trade Agreement,

12/04/2025

Resources:

Resources:

C4IP Comments RE: Revision to Rules of Practice Before PTAB (PTO-P-2025-0025),

12/02/2025

Resources:

Resources:

PREVAIL in Comparison to the Current and Previous Administration’s Procedures for PTAB,

11/17/2025

Resources:

Resources:

C4IP Comments RE: India’s Invitation to Comment on Its Drug Approval Regime,

11/06/2025

Resources:

Resources:

C4IP Comments RE: Operation of the Agreement between the United States of America, the United Mexican States, and Canada (USTR-2025-0004),

11/03/2025

C4IP:

C4IP, Resources:

C4IP Letter to Senate and House IP Subcommittees RE: Designating October as National IP Month,

10/21/2025

Resources:

Resources:

C4IP Letter to Senate Judiciary Subcommittee on Intellectual Property RE: PERA Hearing,

10/07/2025

Resources:

Resources:

C4IP Comments RE: U.K. IPO Consultation on SEPs,

10/03/2025

Scroll to Top